Bahman Salehi

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi et al. · Depression and Anxiety · 2009 · 392 citations

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia

Mehdi Farokhnia, Anita Azarkolah, Forod Adinehfar et al. · Clinical Neuropharmacology · 2013 · 154 citations

Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia

Amirhossein Modabbernia, Farzin Rezaei, Bahman Salehi et al. · CNS Drugs · 2012 · 103 citations

Psychiatry, Medicine, Psychopharmacology +6

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study

Mohammad Reza Khodaie Ardakani, Omid Mirshafiee, Mehdi Farokhnia et al. · Psychiatry Research · 2014 · 102 citations

Double-blind Placebo-controlled Study, Psychiatry, Psychotic Disorder +12

Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism

Shahin Akhondzadeh, Jalil Fallah, Mohammad-Reza Mohammadi et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2009 · 101 citations

Psychiatry, Medicine, Autism +6